Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
September 30, 2024 4.089M
June 30, 2024 7.279M
March 31, 2024 2.202M
December 31, 2023 0.812M
September 30, 2023 21.70M
June 30, 2023 18.39M
March 31, 2023 11.85M
December 31, 2022 0.748M
September 30, 2022 23.18M
June 30, 2022 3.921M
March 31, 2022 1.202M
December 31, 2021 0.239M
September 30, 2021 0.024M
June 30, 2021 20.22M
March 31, 2021 0.053M
December 31, 2020 0.112M
September 30, 2020 32.40M
June 30, 2020 13.00M
March 31, 2020 40.10M
December 31, 2019 4.965M
September 30, 2019 1.617M
June 30, 2019 0.112M
March 31, 2019 -0.344M
Date Value
December 31, 2018 -0.089M
September 30, 2018 -0.04M
June 30, 2018 50.13M
March 31, 2018 -0.348M
December 31, 2017 -0.146M
September 30, 2017 18.56M
June 30, 2017 0.407M
March 31, 2017 -0.314M
December 31, 2016 9.569M
September 30, 2016 37.67M
June 30, 2016 4.665M
March 31, 2016 -0.149M
December 31, 2015 44.24M
September 30, 2015 -0.003M
June 30, 2015 0.636M
March 31, 2015 0.30M
December 31, 2014 7.79M
September 30, 2014 67.75M
June 30, 2014 -1.177M
March 31, 2014 -0.446M
December 31, 2013 -0.38M
September 30, 2013 -0.374M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
ABVC BioPharma, Inc. 0.4087M
Anika Therapeutics, Inc. -0.027M
Perspective Therapeutics, Inc. 0.175M
MiMedx Group, Inc. -18.65M
Abbott Laboratories -2.405B